GCIA
APEN

Gabelli & Co Investment Advisers’s Apollo Endosurgery, Inc. APEN Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-791,772
Closed -$7.85M – 332
2023
Q1 		$7.85M Buy
791,772
+599,922
+313% +$5.94M 1.51% 19
2022
Q4 		$1.91M Buy
+191,850
New +$1.43M 0.41% 48

Gabelli & Co Investment Advisers's APEN Position: Q2 2023 in Review

Gabelli & Co Investment Advisers sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 791,772 shares — an estimated $7.85M sold.

Gabelli & Co Investment Advisers first reported a position in APEN in Q4 2022 and held it in 2 quarters. The position peaked at $7.85M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

  • Gabelli & Co Investment Advisers reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 791,772 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $7.85M.
  • Gabelli & Co Investment Advisers first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 2 quarters.
  • Gabelli & Co Investment Advisers's Apollo Endosurgery, Inc. position peaked at $7.85M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2023, filed 10 Aug 2023.